tirzepatide fda news says shortage of GLP-1 drug is over The Impact of New FDA

The agreement followed negotiations between the Trump administration, Novo Nordisk and Eli Lilly earlier this month, aimed at expanding access to obesity and diabetes treatments within Medicare and Medicaid programs

$250 per month, plus the cost of medication 3-month initial commitment required (Can pay monthly or receive 10% discount if paid in full) What is the cost of the medication

I would not recommend it as a first-line approach

& Sakimura, K

They are structurally and functionally distinct research compounds

This information may help provide context for provider conversations about which formulation and dose strategy could align with an individual's genetic profile, though genetic variants do not predict exact medication response